Filters
Term Search
You can select from the dropdown list OR enter your own terms to refine the search.
Last Updated: 10/31/2025
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 6 publications
Prademagene zamikeracel (Zevaskyn) for recessive dystrophic epidermolysis bullosa.
Journal: The Medical letter on drugs and therapeutics
Published: July 12, 2025
Towards Extracellular Vesicles in the Treatment of Epidermolysis Bullosa.
Journal: Bioengineering (Basel, Switzerland)
Published: March 19, 2025
VYJUVEK for dystrophic epidermolysis bullosa: Ethical dilemmas in access and pricing.
Journal: Journal of the American Academy of Dermatology
Published: February 20, 2025
Herpes simplex virus gene therapy for dystrophic epidermolysis bullosa (DEB).
Journal: Cell
Published: August 18, 2023
Revolutionary breakthrough: FDA approves Vyjuvek, the first topical gene therapy for dystrophic epidermolysis bullosa.
Journal: Annals of medicine and surgery (2012)
Published: June 07, 2023
Showing 1-6 of 6
Last Updated: 10/31/2025